Form 4 ARDELYX, INC. For: Feb 20 Filed by: Renz Justin A
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Qtrex Quantum executives plan to buy up to 2M shares over 12 months
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
Ardelyx, Inc (ARDX) PT Raised to $13 at H.C. Wainwright
February 23, 2024 6:08 AM ESTH.C. Wainwright analyst Ed Arce raised the price target on Ardelyx, Inc (NASDAQ: ARDX) to $13.00 (from $11.00) while maintaining a Buy rating.
The analyst comments "We project U.S. IBSRELA annual net sales growth of 84% in 2024. Yesterday, Ardelyx announced 2023 U.S. IBSRELA net sales for irritable bowel syndrome (IBS-C) of $80.1M, largely in-line with... More
